BioSpace News Archive

IgGenix, Inc., a pre-clinical biotechnology company taking a revolutionary approach to directly address allergic disease, today announced its first close on a $40M Series B financing to advance its lead program in peanut allergy to the clinic.

Chronic kidney disease (CKD) in children is rare, which makes it difficult to study and leaves major gaps in the quantity and quality of evidence that informs the care of pediatric patients with the condition.

Hillstream BioPharma, Inc. will be hosting a virtual R&D Day on Tuesday, February 14, 2023.

Singular Genomics Systems, Inc. today released new data from 11 industry-leading genomics partners that validate the performance and versatility of the G4 Sequencing Platform.

GlycoMimetics, Inc. (the “Company”) (NASDAQ:GLYC) today announced that the Compensation Committee of the Company’s Board of Directors approved the grant on January 31 , 2023 of a non-qualified stock option award to purchase an aggregate of 100,000 shares to Debora Peralta, the Company’s new Vice President, Commercial Operations.

Sirona Medical today announced that William R. Brody, MD, PhD has joined the company’s Board of Directors to help elevate radiology’s impact on clinical healthcare.

Inozyme Pharma, Inc. today announced that it will host an Investor and Analyst Event on Thursday, Feb. 16, 2023 at 8 a.m. ET.

Concerto Biosciences announced today that it has appointed Didier Vingadassalom, Ph.D., MBA, as Senior Director, Business Development.

Organon (NYSE: OGN), a global women’s healthcare company will release its fourth quarter and full year 2022 financial results on February 16, 2023, prior to the company’s webcast and conference call scheduled for 8:30 a.m. EST.

scPharmaceuticals Inc. announced that on February 1, 2023, the Compensation Committee of scPharmaceuticals’ board of directors granted inducement equity grants consisting of stock options to purchase an aggregate of 142,500 shares of its common stock to 38 new employees.